The mechanisms of carnosic acid attenuates tumor necrosis factor-α-mediated inflammation and insulin resistance in 3T3-L1 adipocytes

Molecular Nutrition and Food Research

Volumn 58, Issue 4, 2014, Pages 654-664

  Tsai, Chia Wen ^a   Liu, Kai Li ^b   Lin, Yu Ru ^a   Kuo, Wen Cheng ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

3T3 L1 adipocytes; Carnosic acid; Inflammation; Insulin resistance; Tumor necrosis factor

Indexed keywords

ABIETANE DERIVATIVE; CARNOSIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; MTOR PROTEIN, MOUSE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE; PLANT EXTRACT; PROTEIN KINASE B; TARGET OF RAPAMYCIN KINASE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

3T3 CELL LINE; ANIMAL; CELL CULTURE; CELL SURVIVAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; INFLAMMATION; INSULIN RESISTANCE; LIVER CELL; MALE; METABOLISM; MOUSE; SPRAGUE DAWLEY RAT;

3T3-L1 CELLS; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; DITERPENES, ABIETANE; GENE EXPRESSION REGULATION; HEPATOCYTES; INFLAMMATION; INSULIN; INSULIN RESISTANCE; MALE; MICE; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; PLANT EXTRACTS; PPAR GAMMA; PROTO-ONCOGENE PROTEINS C-AKT; RATS, SPRAGUE-DAWLEY; TOR SERINE-THREONINE KINASES; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84897056659     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300356     Document Type: Article

References (57)

1. Fernandez-Veledo, S., Nieto-Vazquez, I., Vila-Bedmar, R., Garcia-Guerra, L. et al., Molecular mechanisms involved in obesity-associated insulin resistance: therapeutical approach. Arch. Physiol. Biochem. 2009, 115, 227-239.
2. Xie, L., Ortega, M. T., Mora, S., Chapes, S. K., Interactive changes between macrophages and adipocytes. Clin. Vaccine Immunol. 2010, 17, 651-659.
3. Vinolo, M. A., Rodrigues, H., Festuccia, W. T., Crisma, A. et al., Tributyrin attenuates obesity-associated inflammation and insulin resistance in high-fat fed mice. Am. J. Physiol. Endocrinol. Metab. 2012, 303, E272-E282.
4. Sakurai, T., Ogasawara, J., Kizaki, T., Ishibashi, Y. et al., Preventive and improvement effects of exercise training and supplement intake in white adipose tissues on obesity and lifestyle-related diseases. Environ. Health Prev. Med. 2012, 17, 348-356.
5. Hotamisligil, G. S., Shargill, N. S., Spiegelman, B. M., Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259, 87-91.
6. Uysal, K. T., Wiesbrock, S. M., Marino, M. W., Hotamisligil, G. S., Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997, 389, 610-614.
7. Gual, P., Le Marchand-Brustel, Y., Tanti, J. F., Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 2005, 87, 99-109.
8. Boura-Halfon, S., Zick, Y., Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 2009, 296, E581-E591.
9. Tanti, J. F., Jager, J., Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation. Curr. Opin. Pharmacol. 2009, 9, 753-762.
10. Jin, L., Shi, G., Ning, G., Li, X. et al., Andrographolide attenuates tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes. Mol. Cell Endocrinol. 2011, 332, 134-139.
11. Chuang, C. C., Bumrungpert, A., Kennedy, A., Overman, A. et al., Grape powder extract attenuates tumor necrosis factor alpha-mediated inflammation and insulin resistance in primary cultures of human adipocytes. J. Nutr. Biochem. 2011, 22, 89-94.
12. Arkan, M. C., Hevener, A. L., Greten, F. R., Maeda, S. et al., IKK-beta links inflammation to obesity-induced insulin resistance. Nat. Med. 2005, 11, 191-198.
13. Viana Abranches, M., Esteves de Oliveira, F. C., Bressan, J., Peroxisome proliferator-activated receptor: effects on nutritional homeostasis, obesity and diabetes mellitus. Nutr. Hosp. 2011, 26, 271-279.
14. Li, H. X., Xiao, L., Wang, C., Gao, J. L. et al., Review: epigenetic regulation of adipocyte differentiation and adipogenesis. J. Zhejiang Univ. Sci. B 2010, 11, 784-791.
15. Fan, W., Imamura, T., Sonoda, N., Sears, D. D. et al., FOXO1 transrepresses peroxisome proliferator-activated receptor gamma transactivation, coordinating an insulin-induced feed-forward response in adipocytes. J. Biol. Chem. 2009, 284, 12188-12197.
16. Foryst-Ludwig, A., Hartge, M., Clemenz, M., Sprang, C. et al., PPARgamma activation attenuates T-lymphocyte-dependent inflammation of adipose tissue and development of insulin resistance in obese mice. Cardiovasc. Diabetol. 2010, 9, 64-72.
17. Salih, D. A., Brunet, A., FoxO transcription factors in the maintenance of cellular homeostasis during aging. Curr. Opin. Cell. Biol. 2008, 20, 126-136.
18. Ponugoti, B., Dong, G., Graves, D. T., Role of forkhead transcription factors in diabetes-induced oxidative stress. Exp. Diabetes Res. 2012, 2012, 939751-939757.
19. Ito, Y., Daitoku, H., Fukamizu, A., FoxO1 increases pro-inflammatory gene expression by inducing C/EBPbeta in TNF-alpha-treated adipocytes. Biochem. Biophys. Res. Commun. 2009, 378, 290-295.
20. Nakae, J., Cao, Y., Oki, M., Orba, Y. et al., Forkhead transcription factor FoxO1 in adipose tissue regulates energy storage and expenditure. Diabetes 2008, 57, 563-576.
21. Armoni, M., Harel, C., Karni, S., Chen, H. et al., FOXO1 represses peroxisome proliferator-activated receptor-gamma1 and -gamma2 gene promoters in primary adipocytes. A novel paradigm to increase insulin sensitivity. J. Biol. Chem. 2006, 281, 19881-19891.
22. Ibarra, A., Cases, J., Bily, A., He, K. et al., Importance of extract standardization and in vitro/ex vivo assay selection for the evaluation of antioxidant activity of botanicals: a case study on three Rosmarinus officinalis L. extracts. J. Med. Food 2010, 13, 1167-1175.
23. Ibarra, A., Cases, J., Roller, M., Chiralt-Boix, A. et al., Carnosic acid-rich rosemary (Rosmarinus officinalis L.) leaf extract limits weight gain and improves cholesterol levels and glycaemia in mice on a high-fat diet. Br. J. Nutr. 2011, 106, 1182-1189.
24. Harach, T., Aprikian, O., Monnard, I., Moulin, J. et al., Rosemary (Rosmarinus officinalis L.) leaf extract limits weight gain and liver steatosis in mice fed a high-fat diet. Planta. Med. 2010, 76, 566-571.
25. Wijeratne, S. S., Cuppett, S. L., Potential of rosemary (Rosemarinus officinalis L.) diterpenes in preventing lipid hydroperoxide-mediated oxidative stress in Caco-2 cells. J. Agric. Food Chem. 2007, 55, 1193-1199.
26. Haraguchi, H., Saito, T., Okamura, N., Yagi, A., Inhibition of lipid peroxidation and superoxide generation by diterpenoids from Rosmarinus officinalis. Planta. Med. 1995, 61, 333-336.
27. Mengoni, E. S., Vichera, G., Rigano, L. A., Rodriguez-Puebla, M. L. et al., Suppression of COX-2, IL-1beta and TNF-alpha expression and leukocyte infiltration in inflamed skin by bioactive compounds from Rosmarinus officinalis L. Fitoterapia 2011, 82, 414-421.
28. Oh, J., Yu, T., Choi, S. J., Yang, Y. et al., Syk/Src pathway-targeted inhibition of skin inflammatory responses by carnosic acid. Mediators Inflamm. 2012, 2012, 781375-781387.
29. Wang, T., Takikawa, Y., Satoh, T., Yoshioka, Y. et al., Carnosic acid prevents obesity and hepatic steatosis in ob/ob mice. Hepatol. Res. 2011, 41, 87-92.
30. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council. Guide for the Care and Use of Laboratory Animals, National Academy Press, Washington, DC 1985.
31. Shi, J., Kandror, K. V., Study of glucose uptake in adipose cells. Methods Mol. Biol. 2008, 456, 307-315.
32. Kaminska, B., MAPK signalling pathways as molecular targets for anti-inflammatory therapy-from molecular mechanisms to therapeutic benefits. Biochim. Biophys. Acta 2005, 1754, 253-262.
33. Adochio, R., Leitner, J. W., Hedlund, R., Draznin, B., Rescuing 3T3-L1 adipocytes from insulin resistance induced by stimulation of Akt-mammalian target of rapamycin/p70 S6 kinase (S6K1) pathway and serine phosphorylation of insulin receptor substrate-1: effect of reduced expression of p85alpha subunit of phosphatidylinositol 3-kinase and S6K1 kinase. Endocrinology 2009, 150, 1165-1173.
34. Weichhart, T., Costantino, G., Poglitsch, M., Rosner, M. et al., The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity 2008, 29, 565-577.
35. Lorne, E., Zhao, X., Zmijewski, J. W., Liu, G. et al., Participation of mammalian target of rapamycin complex 1 in Toll-like receptor 2- and 4-induced neutrophil activation and acute lung injury. Am. J. Respir. Cell Mol. Biol. 2009, 41, 237-245.
36. Overman, A., Bumrungpert, A., Kennedy, A., Martinez, K. et al., Polyphenol-rich grape powder extract (GPE) attenuates inflammation in human macrophages and in human adipocytes exposed to macrophage-conditioned media. Int. J. Obes. (Lond.) 2010, 34, 800-808.
37. Ding, L., Jin, D., Chen, X., Luteolin enhances insulin sensitivity via activation of PPARgamma transcriptional activity in adipocytes. J. Nutr. Biochem. 2010, 21, 941-947.
38. Nagasaki, H., Yoshimura, T., Aoki, N., Real-time monitoring of inflammation status in 3T3-L1 adipocytes possessing a secretory Gaussia luciferase gene under the control of nuclear factor-kappa B response element. Biochem. Biophys. Res. Commun. 2012, 420, 623-627.
39. Wang, T., Takikawa, Y., Tabuchi, T., Satoh, T. et al., Carnosic acid (CA) prevents lipid accumulation in hepatocytes through the EGFR/MAPK pathway. J. Gastroenterol. 2012, 47, 805-813.
40. Khan, A. H., Pessin, J. E., Insulin regulation of glucose uptake: a complex interplay of intracellular signalling pathways. Diabetologia 2002, 45, 1475-1483.
41. Zabolotny, J. M., Kim, Y. B., Welsh, L. A., Kershaw, E. E. et al., Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo. J. Biol. Chem. 2008, 283, 14230-14241.
42. Lee, D. F., Kuo, H. P., Chen, C. T., Hsu, J. M. et al., IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 2007, 130, 440-455.
43. Ozes, O. N., Akca, H., Mayo, L. D., Gustin, J. A. et al., A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proc. Natl. Acad. Sci. USA 2001, 98, 4640-4645.
44. Ozcan, U., Ozcan, L., Yilmaz, E., Duvel, K. et al., Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis. Mol. Cell 2008, 29, 541-551.
45. Harrington, L. S., Findlay, G. M., Gray, A., Tolkacheva, T. et al., The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J. Cell Biol. 2004, 166, 213-223.
46. Schaeffer, V., Abrass, C. K., Mechanisms and control of protein translation in the kidney. Am. J. Nephrol. 2010, 31, 189-201.
47. Zhu, X., Liu, Q., Wang, M., Liang, M. et al., Activation of Sirt1 by resveratrol inhibits TNF-alpha induced inflammation in fibroblasts. PLoS One 2011, 6, e27081.
48. Ricote, M., Glass, C. K., PPARs and molecular mechanisms of transrepression. Biochim. Biophys. Acta 2007, 1771, 926-935.
49. Camp, H. S., Tafuri, S. R., Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase. J. Biol. Chem. 1997, 272, 10811-10816.
50. Ruan, H., Pownall, H. J., Lodish, H. F., Troglitazone antagonizes tumor necrosis factor-alpha-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-kappaB. J. Biol. Chem. 2003, 278, 28181-28192.
51. Hosooka, T., Noguchi, T., Kotani, K., Nakamura, T. et al., Dok1 mediates high-fat diet-induced adipocyte hypertrophy and obesity through modulation of PPAR-gamma phosphorylation. Nat. Med. 2008, 14, 188-193.
52. Ye, J., Regulation of PPARgamma function by TNF-alpha. Biochem. Biophys. Res. Commun. 2008, 374, 405-408.
53. Sun, Z., Miller, R. A., Patel, R. T., Chen, J. et al., Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration. Nat. Med. 2012, 18, 934-942.
54. Li, D., Wang, X., Ren, W., Ren, J. et al., High expression of liver histone deacetylase 3 contributes to high-fat-diet-induced metabolic syndrome by suppressing the PPAR-gamma and LXR-alpha-pathways in E3 rats. Mol. Cell Endocrinol. 2011, 344, 69-80.
55. Dominy, J. E., Puigserver, P., Nuclear FoxO1 inflames insulin resistance. EMBO J. 2010, 29, 4068-4069.
56. Brent, M. M., Anand, R., Marmorstein, R., Structural basis for DNA recognition by FoxO1 and its regulation by posttranslational modification. Structure 2008, 16, 1407-1416.
57. Tzivion, G., Dobson, M., Ramakrishnan, G., FoxO transcription factors; regulation by AKT and 14-3-3 proteins. Biochim. Biophys. Acta 2011, 1813, 1938-1945.